Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
Main Authors: | , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2022
|
Main Authors: | , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2022
|